Autoimmune Hemolytic Anemia Triggered by Neoadjuvant Pembrolizumab in Triple Negative Breast Cancer: A R – Research
Files
Publication Date
4-30-2026
Content Type
poster_control
Recommended Citation
Slaybe, Angela, "Autoimmune Hemolytic Anemia Triggered by Neoadjuvant Pembrolizumab in Triple Negative Breast Cancer: A R – Research" (2026). 2026 Baptist Health Academic Conference: The Art and Science of Interprofessional Collaborations. 225.
https://scholarlycommons.baptisthealth.net/bhsf-academic-week-2026/225